Legal entity
Every one of those 1 sits in a single category, corporate-law. Of the tracked stories, 1 of 1 also mention Enphase Energy, the most common co-covered peer. Their average consequence score of 5 runs below the beat's 6.1 for that window.
Last mentioned: Mar 22, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, corporate-law. Of the tracked stories, 1 of 1 also mention Enphase Energy, the most common co-covered peer. Their average consequence score of 5 runs below the beat's 6.1 for that window. Each story carries 3 original sources on average, compared with 2.7 for the broader beat in this window. We currently track 1 Legal story that mention Nektar Therapeutics, all published on March 22, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 39 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Nektar Therapeutics. Shared-story counts are live from our verified record — not editorial picks.
Enphase Suit Filed
Pomerantz LLP files class action litigation against Enphase Energy in federal court.
Litigation Launch
Pomerantz LLP officially announces class action litigation against Nektar Therapeutics.
Nektar Financial Update
Nektar files updated results of operations and financial condition reports.
Nektar Disclosure
Nektar Therapeutics issues Regulation FD disclosure regarding its business operations.
Enphase Financials
Enphase Energy files results of operations with the SEC, highlighting market challenges.
Pomerantz LLP has initiated class action lawsuits against Nektar Therapeutics and Enphase Energy, alleging violations of federal securities laws. The litigation follows a series of financial disclosures and regulatory filings in early 2026 that triggered significant market volatility for both companies.
Source: pr-inside.com · pr-inside.com
Nektar Therapeutics is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
